Immunogenicity 15119
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
TRMT44
Transcript ID
uc003glg.2
HLA INFO
B*38:01
TCR INFO
No TCR info found!
Full length protein sequence (757 aa)
MAEVG
1
RTGIS
6
YPGAL
11
LPQGF
16
WAAVE
21
VWLER
26
PQVAN
31
KRLCG
36
ARLEA
41
RWSAA
46
LPCAE
51
ARGPG
56
TSAGS
61
EQKER
66
GPGPG
71
QGSPG
76
GGPGP
81
RSLSG
86
PEQGT
91
ACCEL
96
EEAQG
101
QCQQE
106
EAQRE
111
AASVP
116
LRDSG
121
HPGHA
126
EGREG
131
DFPAA
136
DLDSL
141
WEDFS
146
QSLAR
151
GNSEL
156
LAFLT
161
SSGAG
166
SQPEA
171
QRELD
176
VVLRT
181
VIPKT
186
SPHCP
191
LTTPR
196
REIVV
201
QDVLN
206
GTITF
211
LPLEE
216
DDEGN
221
LKVKM
226
SNVYQ
231
IQLSH
236
SKEEW
241
FISVL
246
IFCPE
251
RWHSD
256
GIVYP
261
KPTWL
266
GEELL
271
AKLAK
276
WSVEN
281
KKSDF
286
KSTLS
291
LISIM
296
KYSKA
301
YQELK
306
EKYKE
311
MVKVW
316
PEVTD
321
PEKFV
326
YEDVA
331
IAAYL
336
LILWE
341
EERAE
346
RRLTA
351
RQSFV
356
DLGCG
361
NGLLV
366
HILSS
371
EGHPG
376
RGIDV
381
RRRKI
386
WDMYG
391
PQTQL
396
EEDAI
401
TPNDK
406
TLFPD
411
VDWLI
416
GNHSD
421
ELTPW
426
IPVIA
431
ARSSY
436
NCRFF
441
VLPCC
446
FFDFI
451
GRYSR
456
RQSKK
461
TQYRE
466
YLDFI
471
KEVGF
476
TCGFH
481
VDEDC
486
LRIPS
491
TKRVC
496
LVGKS
501
RTYPS
506
SREAS
511
VDEKR
516
TQYIK
521
SRRGC
526
PVSPP
531
GWELS
536
PSPRW
541
VAAGS
546
AGHCD
551
GQQAL
556
DARVG
561
CVTRA
566
WAAEH
571
GAGPQ
576
AEGPW
581
LPGFH
586
PREKA
591
ERVRN
596
CAALP
601
RDFID
606
QVVLQ
611
VANLL
616
LGGKQ
621
LNTRS
626
SRNGS
631
LKTWN
636
GGESL
641
SLAEV
646
ANELD
651
TETLR
656
RLKRE
661
CGGLQ
666
TLLRN
671
SHQVF
676
QVVNG
681
RVHIR
686
DWREE
691
TLWKT
696
KQPEA
701
KQRLL
706
SEACK
711
TRLCW
716
FFMHH
721
PDGCA
726
LSTDC
731
CPFAH
736
GPAEL
741
RPPRT
746
TPRKK
751
IS
756
Mutation Information
DNA mutation:
None
Peptide Range:
376 ~ 400
Mut AA position:
None (None in Wild Type peptide)
Alignment
Wild Type:
"EGHPGRGIDVRRRKIWDMYGPQTQL
||||||||||||.||||||||||||
Mutant:
EGHPGRGIDVRRKKIWDMYGPQTQL"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) C4orf23
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay